BFM
CNTB

Boothbay Fund Management’s Connect Biopharma Holdings CNTB Stock Holding History

Boothbay Fund Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-37,000
Closed -$96.9K – 2300
2026
Q1 		$96.9K Hold
37,000
– – ﹤0.01% 1879
2025
Q4 		$104K Buy
+37,000
New +$78.9K ﹤0.01% 1735

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Boothbay Fund Management's CNTB Position: Q2 2026 in Review

Boothbay Fund Management reduced its Connect Biopharma Holdings (CNTB) stake by 21% in Q2 2026, selling an estimated $632K and leaving 973,732 shares worth $2.32M. The position accounts for 0.03% of the portfolio, ranked #662.

Boothbay Fund Management first reported a position in CNTB in Q4 2021 and has held it in 10 quarters since. The position peaked at $3.48M in Q4 2025. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Boothbay Fund Management held 973,732 shares of Connect Biopharma Holdings worth $2.32M as of Q2 2026.
  • Boothbay Fund Management sold 260,850 Connect Biopharma Holdings shares in Q2 2026, an estimated $632K.
  • Connect Biopharma Holdings made up 0.03% of Boothbay Fund Management's portfolio in Q2 2026, its #662 holding.
  • Boothbay Fund Management first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 10 quarters since.
  • Boothbay Fund Management's Connect Biopharma Holdings position peaked at $3.48M in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.